( September 5, 2025, 4:48 PM EDT) -- CHICAGO — The Seventh Circuit U.S. Court of Appeals affirmed a lower court’s order dismissing a False Claims Act (FCA) suit filed by a man against AbbVie Inc. regarding alleged fraud for off-label use of a medication for a government-insured patient and retaliation against the plaintiff as a whistleblower, finding that “AbbVie could not have retaliated against” the man as a whistleblower because he did not blow the whistle on fraud....